Time-dependent changes in striatal glutamate synapses following a 6-hydroxydopamine lesion, Neuroscience, vol.88, issue.1, pp.1-16, 1999. ,
DOI : 10.1016/S0306-4522(98)00189-4
Dopamine-glutamate interactions in the basal ganglia, Amino Acids, vol.22, issue.1-3, pp.5-10, 1998. ,
DOI : 10.1007/BF01345235
Chronic l-DOPA treatment increases extracellular glutamate levels and GLT1 expression in the basal ganglia in a rat model of Parkinson's disease, European Journal of Neuroscience, vol.14, issue.5, pp.1255-1266, 2004. ,
DOI : 10.1002/(SICI)1098-2396(199711)27:3<242::AID-SYN9>3.0.CO;2-D
MK801 suppresses the l-DOPA-induced increase of glutamate in striatum of hemi-Parkinson rats, Brain Research, vol.926, issue.1-2, pp.149-155, 2002. ,
DOI : 10.1016/S0006-8993(01)03147-X
Unchanged basal gangliaN-acetylaspartate and glutamate in idiopathic Parkinson's disease measured by proton magnetic resonance spectroscopy, Movement Disorders, vol.34, issue.3, pp.297-301, 1997. ,
DOI : 10.1002/mds.870120306
Basal ganglia metabolite concentrations in idiopathic Parkinson's disease and multiple system atrophy measured by proton magnetic resonance spectroscopy, European Journal of Neurology, vol.69, issue.6, pp.661-665, 2000. ,
DOI : 10.1046/j.1468-1331.2000.00111.x
A proton magnetic resonance spectroscopy study of the striatum and cerebral cortex in Parkinson's disease, Metabolic Brain Disease, vol.14, issue.1, pp.45-55, 1999. ,
DOI : 10.1023/A:1020609530444
Measurement of brain glutamate using TE-averaged PRESS at 3T, Magnetic Resonance in Medicine, vol.18, issue.3, pp.435-440, 2004. ,
DOI : 10.1002/mrm.20007
Posteroventral Medial Pallidotomy in Advanced Parkinson's Disease, New England Journal of Medicine, vol.337, issue.15, pp.1036-1042, 1997. ,
DOI : 10.1056/NEJM199710093371503
Atlas d'anatomie Céphalique dans le Plan Neuro-Oculaire (PNO) Thesis University, 1983. ,
Automatic, localizedin Vivo adjustment of all first-and second-order shim coils, Magnetic Resonance in Medicine, vol.89, issue.6, pp.804-811, 1993. ,
DOI : 10.1002/mrm.1910290613
The application of phase rotation for localized in Vivo proton spectroscopy with short echo times, Journal of Magnetic Resonance (1969), vol.96, issue.1, pp.40-49, 1992. ,
DOI : 10.1016/0022-2364(92)90286-G
Java-based graphical user interface for the MRUI quantitation package, Magma: Magnetic Resonance Materials in Physics, Biology, and Medicine, vol.6, issue.2-3, pp.141-152, 2001. ,
DOI : 10.1007/BF02668096
Improved Method for Accurate and Efficient Quantification of MRS Data with Use of Prior Knowledge, Journal of Magnetic Resonance, vol.129, issue.1, pp.35-43, 1997. ,
DOI : 10.1006/jmre.1997.1244
Proton NMR chemical shifts and coupling constants for brain metabolites, NMR in Biomedicine, vol.18, issue.3, pp.129-153, 2000. ,
DOI : 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V
Functional anatomy of the basal ganglia, Movement Disorders, vol.12, issue.S3, pp.15-21, 2002. ,
DOI : 10.1002/mds.10138
TE-Averaged two-dimensional proton spectroscopic imaging of glutamate at 3 T, NeuroImage, vol.30, issue.4, pp.1171-1178, 2006. ,
DOI : 10.1016/j.neuroimage.2005.10.048
Analysis of macromolecule resonances in1H NMR spectra of human brain, Magnetic Resonance in Medicine, vol.25, issue.3, pp.294-302, 1994. ,
DOI : 10.1002/mrm.1910320304
In press DOI: 10.1002/nbm GLUTAMATE AND PARKINSON'S DISEASE 20 High magnetic field water and metabolite proton T1 and T2 relaxation in rat brain in vivo, Ltd. NMR Biomed Magn Reson Med, vol.56, pp.386-394, 2006. ,
The effect of 6-hydroxydopamine lesions on the release of amino acids in the direct and indirect pathways of the basal ganglia: a dual microdialysis probe analysis, Eur J Neurosci, vol.18, pp.856-868, 2003. ,
Adenosine A2A receptor antagonism increases striatal glutamate outflow in dopamine-denervated rats, European Journal of Pharmacology, vol.464, issue.1, pp.33-38, 2003. ,
DOI : 10.1016/S0014-2999(03)01352-9
In vivo neurochemical monitoring and the study of behaviour, Neuroscience & Biobehavioral Reviews, vol.29, issue.6, pp.949-962, 2005. ,
DOI : 10.1016/j.neubiorev.2005.02.003
T2 relaxation time in patients with Parkinson's disease, Neurology, vol.43, issue.4, pp.697-700, 1993. ,
DOI : 10.1212/WNL.43.4.697
Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence, Brain, vol.123, issue.12, pp.2423-2431, 2000. ,
DOI : 10.1093/brain/123.12.2423
MRI evaluation of the basal ganglia size and iron content in patients with Parkinson's disease, Journal of Neurology, vol.11, issue.1, pp.26-32, 2006. ,
DOI : 10.1007/s00415-005-0914-9